Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

29 projects found matching your search criteria :

  1. Impact of nanoparticles on cancer metastasis - epigenetic mechanisms

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Marcin Kruszewski

    Wyższa Szkoła Informatyki i Zarządzania w Rzeszowie, Wydział Medyczny

  2. Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m...

    Call: HARMONIA 6 , Panel: NZ5

    Principal investigator: dr Tomasz Stokłosa

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  3. Molecular mechanism of epigenetic drugs action to prevent multi-organ injury in a mouse model of sepsis

    Call: HARMONIA 6 , Panel: NZ5

    Principal investigator: dr Michał Mikula

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

  4. Search for the mechanisms of the modulation of canonical Wnt signaling which effectively attenuate the survival of head ...

    Call: SONATA 7 , Panel: NZ7

    Principal investigator: dr Jarosław Paluszczak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  5. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac...

    Call: SONATA 5 , Panel: NZ7

    Principal investigator: dr Magdalena Sowa-Kućma

    Instytut Farmakologii PAN

  6. The 11beta-hydroxysteroid dehydrogenase 2 in pregnant women with hypertension

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: prof. Franciszek Główka

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  7. Functional, epigenetic and genetic aspects of base excision repair pathway in Alzheimer's disease

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Śliwiński

    UNIWERSYTET ŁÓDZKI, Wydział Biologii i Ochrony Środowiska

  8. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Bernadeta Pietrzak-Wawrzyńska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  9. Blood plasma microRNA profile as a basis for detecting Alzheimer's disease and dementia risk in pre-symptomatic individu...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: prof. Urszula Wojda

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  10. Environmental and epigenetic modifications and atopy and allergic diseases prevention in rural population at all ages - ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Barbara Sozańska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

  11. The effect of maternal treatment with metformin in pregnancy and lactation on programming metabolic adverse conditions i...

    Call: SONATA BIS 12 , Panel: NZ7

    Principal investigator: dr hab. Monika Słupecka-Ziemilska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  12. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Przepiórska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding ...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Anna Nowak

    Warszawski Uniwersytet Medyczny

  14. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Agnieszka Woźniak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  15. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Call: SONATA 17 , Panel: NZ7

    Principal investigator: dr Piotr Małecki

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  16. Genetic and epigenetic interaction of exposure to endocrine disrupting chemicals included in everyday use products and e...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Joanna Jurewicz

    Instytut Medycyny Pracy im. prof. dr. med. Jerzego Nofera

  17. Polystyrene nanoparticles and their epigenetic and genotoxic properties in human peripheral blood mononuclear cells

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Kinga Malinowska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  18. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Katarzyna Głombik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Drug metabolizing enzymes (DMEs) in liver pathology, proteomic characteristics, transcriptional and epigenetic regulatio...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Marek Droździk

    Pomorski Uniwersytet Medyczny w Szczecinie

  20. Nanoplastic toxicity: effect on gut-brain axis

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Marcin Kruszewski

    Instytut Chemii i Techniki Jądrowej

  21. MicroRNAs in blood as biomarkers for Alzheimer's disease: molecular signature for personalized therapy

    Call: OPUS 15 , Panel: NZ7

    Principal investigator: prof. Urszula Wojda

    Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

  22. Searching for behavioural and molecular predictors of long-term benzodiazepine administration in preclinical chronic str...

    Call: SONATINA 2 , Panel: NZ7

    Principal investigator: dr Karolina Kołosowska

    Instytut Psychiatrii i Neurologii

  23. A search for mechanism of anticancer properities of vitamin C; possible link between epigenetic DNA modyfications and vi...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  24. Identification of epigenetic mechanisms contributing to glioma drug resistance

    Call: POLONEZ 3 , Panel: NZ2

    Principal investigator: dr Jakub Mieczkowski

    Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

  25. Apoptotic mechanisms in skeletal muscle aging; physical exercise intervention

    Call: PRELUDIUM 11 , Panel: NZ7

    Principal investigator: Barbara Morawin

    Uniwersytet Zielonogórski, Wydział Lekarski i Nauk o Zdrowiu

  26. Cultural changes in the evolution of humans and its effects on the epigenetic mechanisms of modern life-style diseases

    Call: POLONEZ 1 , Panel: NZ7

    Principal investigator: dr Olaf Thalmann

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski I

  27. Epigenetics of periodontitis: alterations in the host protein acetylation system as a potentially fundamental mechanism ...

    Call: POLONEZ 1 , Panel: NZ7

    Principal investigator: dr Aleksander Grabiec

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  28. The role of epigenetic changes and p53 in visceral adipose tissue in the pathogenesis of type 2 diabetes mellitus

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Janusz Szemraj

    Uniwersytet Medyczny w Łodzi, Katedra Biochemii Medycznej

  29. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Call: PRELUDIUM 9 , Panel: NZ3

    Principal investigator: Alicja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN